Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Nasopharyngeal Carcinoma 11Squamous Cell Carcinoma of Head and Neck 9Small Cell Lung Carcinoma 9Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Biliary Tract Neoplasms 5Lung Neoplasms 4Cholangiocarcinoma 4Stomach Neoplasms 3Neoplasm Metastasis 3Nasopharyngeal Neoplasms 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Recurrence 2Ovarian Neoplasms 2Neoplasms 2NSCLC 2Esophageal Neoplasms 2Breast Neoplasms 2Unresectable Locally Advanced or Metastatic Solid Tumors 1Triple Negative Breast Neoplasms 1Tongue Squamous Cell Carcinoma 1Thyroid Neoplasms 1Thymoma 1Thymic epithelial tumor 1Solid Tumor Cancer 1Rare Tumour 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

apatinib 1Surgical Procedures, Operative 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Thymic epithelial tumor × Cisplatin × Clear all
NCT07463313 2026-03-11

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2/3 Not yet recruiting
116 enrolled
Thoracic

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡